These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3033534)

  • 1. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat.
    Leadem CA; Yagenova SV
    Neuroendocrinology; 1987 Feb; 45(2):109-17. PubMed ID: 3033534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes.
    Walsh JP; Clarke IJ
    Endocrinology; 1996 Sep; 137(9):3640-8. PubMed ID: 8756528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medial preoptic-anterior hypothalamic area involvement in the suppression of pulsatile LH release by a mu-opioid agonist in the ovariectomized rat.
    Mallory DS; Gallo RV
    Brain Res Bull; 1990 Aug; 25(2):251-7. PubMed ID: 2171721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
    Leadem CA; Kalra SP
    Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
    Bero LA; Lurie SN; Kuhn CM
    Brain Res; 1987 Dec; 465(1-2):189-96. PubMed ID: 2894234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC; West TE; Wise RA
    Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mu opioid receptors in the pre-optic-anterior hypothalamus releases prolactin in the conscious male rat.
    Kapoor R; Willoughby JO
    Neuropeptides; 1991 Aug; 19(4):231-6. PubMed ID: 1681455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
    Bot G; Chahl LA; Brent PJ; Johnston PA
    Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion.
    Pfeiffer DG; Pfeiffer A; Almeida OF; Herz A
    J Endocrinol; 1987 Sep; 114(3):469-76. PubMed ID: 2822829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats.
    Jackson HC; Kitchen I
    Psychopharmacology (Berl); 1989; 97(3):404-9. PubMed ID: 2541460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
    Sheldon RJ; Nunan L; Porreca F
    Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.